The influence of total intravenous anaesthesia and isoflurane anaesthesia on plasma interleukin-6 and interleukin-10 concentrations after colorectal surgery for cancer A randomised controlled trial

European Journal of Anaesthesiology

Volumn 31, Issue 12, 2014, Pages 678-684

  Margarit, Simona C ^a   Vasian, Horatiu N ^a   Balla, Erika ^c   Vesa, Stefan ^a   Ionescu, Daniela C ^a,b  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Institutul Regional de Gastroenterologie Si Hepatologie Octavian Fodor Sectia ATI   (Romania)

^c Regional Institute of Gastroenterology and Hepatology Prof O Fodor   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; ISOFLURANE; ONDANSETRON; PROPOFOL; REMIFENTANIL; BIOLOGICAL MARKER; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INHALATION ANESTHETIC AGENT;

ADULT; ANESTHESIA INDUCTION; ANESTHESIA LEVEL; ARTICLE; BISPECTRAL INDEX; BODY MASS; CANCER SURGERY; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; CORE TEMPERATURE; END TIDAL CARBON DIOXIDE TENSION; FEMALE; HUMAN; INTRAVENOUS ANESTHESIA; MAJOR CLINICAL STUDY; MALE; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE NAUSEA AND VOMITING; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VISUAL ANALOG SCALE; AGED; BLOOD; COLORECTAL NEOPLASMS; MIDDLE AGED; POSTOPERATIVE PERIOD; TRENDS;

AGED; ANESTHESIA, INTRAVENOUS; ANESTHETICS, INHALATION; BIOLOGICAL MARKERS; COLORECTAL NEOPLASMS; COLORECTAL SURGERY; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; ISOFLURANE; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES;

EID: 84926456460     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0000000000000057     Document Type: Article

References (34)

1. Sheeran P, Hall GM. Cytokines in anaesthesia. Br J Anaesth 1997; 78:201-219.
2. Snyder GL, Greenberg S. Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth 2010; 105:106- 115.
3. Sido B, Teklote JR, Hartel M, et al. Inflammatory response after abdominal surgery. Best Pract Res Clin Anaesth 2004; 18:439-454.
4. Schneemilch CE, Schilling T, Bank U. Effects of general anaesthesia on inflammation. Best Pract Res Clin Anaesthesiol 2004; 18:493-507.
5. Santamaria LB, Schifilliti D, La Tore D, Fodale V. Drugs of anesthesia and cancer. Surg Oncol 2010; 19:63-81.
6. Cruickshank AM, Fraser WD, Burns HJG, et al. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci 1990; 79:161-165.
7. Ohzato H, Yoshizaki K, Nishimoto N, et al. Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery 1992; 111:201-209.
8. Evans C, Galustian C, Kumar D, et al. Impact of surgery on immunologic function: comparison between minimally invasive techniques and conventional laparotomy for surgical resection of colorectal tumors. Am J Surg 2009; 197:238-245.
9. Klampfer L. Cytokines, inflammation and colon cancer. Curr Cancer Drug Targets 2011; 11:451-464.
10. Zammaron BF, Chen WJ. Dual roles of immune cells and their factors in cancer development and progression. Int J Biol Sci 2011; 7:651-658.
11. Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology 2011; 140:1807-1816.
12. Mocellin S, Maricola FM, Young HA. Interleukin-10 and the immune response against cancer: A counterpoint. J Leukoc Biol 2005; 78:1043- 1051.
13. Lin W, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007; 117:1175-1183.
14. Ke JJ, Zhan J, Feng XB, et al. A comparison of the effect of total intravenous anaesthesia with propofol and remifentanil and inhalational anaesthesia with isoflurane on the release of pro- and anti-inflammatory cytokines in patients undergoing open cholecystectomy. Anaesth Intensive Care 2008; 36:74-78.
15. Croizier TA, Müller JE, Quittkat D, et al. Effect of anaesthesia on the cytokine responses to abdominal surgery. Br J Anaesth 1994; 72:280- 285.
16. Gilliland HE, Armstrong MA, Carabine U, McMurray TJ. The choice of anesthetic maintenance technique influences the antiinflammatory cytokine response to abdominal surgery. Anesth Analg 1997; 85:1394- 1398.
17. Kurosawa S, Kato M. Anesthetics, immune cells, and immune responses. J Anesth 2008; 22:263-277.
18. Tylman M, Sarbinowski R, Bengtson JP, et al. Inflammatory response in patients undergoing colorectal cancer surgery: The effect of two different anesthetic techniques. Minerva Anestesiol 2011; 77:275-282.
19. Marik PE. Propofol: An immunomodulating agent. Pharmacotherapy 2005; 25:28S-33S.
20. Chen RM, Chen TG, Chen TL, et al. Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages. Ann N Y Acad Sci 2005; 1042:262-271.
21. Kurosawa S. Anesthesia in patients with cancer disorders. Curr Opin Anaesthesiol 2012; 25:376-384.
22. Gottschalk A, Sharma S, Ford J, et al. The role of perioperative period in recurrence after cancer surgery. Anesth Analg 2010; 110:1636- 1640.
23. Kvarnström AL, Sarbinowski RT, Bengtson JP, et al. Complement activation and interleukin response in major abdominal surgery. Scand J Immunol 2012; 75:510-516.
24. Sofra M, Fei PC, Fabrizi L, et al. Immunomodulatory effects of total intravenous and balanced inhalation anesthesia in patients with bladder cancer undergoing elective radical cystectomy: preliminary results. J Exp Clin Cancer Res 2013; 32:6.
25. Deegan CA, Murray D, Doran P, et al. Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery. Reg Anesth Pain Med 2010; 35:490-495.
26. Melamed R, Bar-Yosef S, Shakhar G, et al. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not propofol: mediating mechanisms and prophylactic measures. Anesth Analg 2003; 97:1331-1339.
27. Inada T, Kubo K, Shingu K. Vaccines using dendritic cells, differentiated with propofol, enhance antitumor immunity in mice. Immunopharmacol Immunotoxicol 2009; 31:150-157.
28. Inada T, Kubo K, Shingu K. Possible link between cyclooxygenaseinhibiting and antitumor properties of propofol. J Anesth 2011; 25:569- 575.
29. Kvolik S, Glavas-Obrovac L, Bares V, Karner I. Effects of inhalation anaesthetics halothane, sevoflurane and isoflurane on human cell line. Life Sci 2005; 77:2369-2383.
30. Ihn CH, Joo JD, Choi JW, et al. Comparison of stress hormone response, interleukin-6 and anaesthetic characteristics of two anaesthetic techniques: volatile induction and maintenance of anaesthesia using sevoflurane versus total intravenous anaesthesia using propofol and remifentanil. J Int Med Res 2009; 37:1760-1771.
31. Afsharimani B, Cabot PJ, Parat MO. Morphine use in cancer surgery. Front Pharmacol 2011; 2:46.
32. Gottschalk A, Sonal Sharma S, Ford J, et al. The role of the perioperative period in recurrence after cancer surgery. Anesth Analg 2010; 110:1636- 1643.
33. Drosos GI, Blatsoukas KS, Ververidis A, et al. Blood transfusion and cytokines' changes in total knee replacement. Arch Orthop Trauma Surg 2012; 132:1505-1513.
34. Okano T, Ohwada S, Sato Y, et al. Blood transfusions impair anastomotic wound healing, reduce luminol-dependent chemiluminescence, and increase interleukin-8. Hepatogastroenterology 2001; 48:1669-1674.